This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Explore how glide paths and passive retirement options work, including risk and cost differences. This intro helps you compare pros and cons before choosing a strategy.
26,696 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Microsoft stock is moving higher in a volatile market, defying a tech sell-off. This article breaks down the drivers ...
A fresh look at a chilling historical echo: the 1987 omen: kevin warsh's. As markets brace for a new Fed chair, inves...
Investors are buzzing about a big quarter from Micron. In micron's explosive earnings report:, the company posted a p...
Option Care earnings season sheds light on the shifting landscape of home infusion and specialty care. This guide bre...
Start your week with a curated set of monday reads that translate headlines into practical investing moves. This guid...
NextEra Energy announces a $67 billion all-stock deal to buy Dominion Energy, a move that could kick off a broader wa...
The memory market has reshaped profits for chip makers and device companies. This article explains how Micron benefit...
Investors looking at cannabis real estate need to understand how Innovative Industrial Properties reports earnings. T...
When Micron announced a Taiwanese site acquisition, micron stock popped today and sparked a broader discussion about ...
A mid-sized fund wrapped up a $9 million exit from a major pawn shop operator after a rally of about 150% over the ye...
San Francisco-based Peregrine Technologies locked in a $250 million Series D as it readies its platform for the 2026 ...